SCHEMBL40378

SCHEMBL40378

CCC(=O)N1CCC(c2nc3c(-c4ccc(-c5ccccc5)nc4)cnn3c3c2C(=O)CCN3)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTOR P42345 5/20 0.42
RPTOR Q8N122 4/20 0.42
MLST8 Q9BVC4 4/20 0.42
ACACB O00763 1/20 0.38
ACACA Q13085 1/20 0.38
CKS1B P61024 1/20 0.37
SKP1 P63208 1/20 0.37
SKP2 Q13309 1/20 0.37
CHEK1 O14757 2/20 0.36
CCNA2 P20248 2/20 0.36
CDK2 P24941 2/20 0.36
CCNA1 P78396 2/20 0.36
HTR2B P41595 2/20 0.35
PIK3CA P42336 1/20 0.34
ALDH1A1 P00352 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
RIPK1 Q13546 1/20 0.34
TMEM97 Q5BJF2 1/20 0.34
MET P08581 1/20 0.34
JAK1 P23458 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL41441 0.94 MTOR (0.42) MTORRPTORMLST8ACACBACACA
SCHEMBL17787546 0.90 MTOR (0.42) MTORRPTORMLST8ACACBACACA
SCHEMBL45386 0.88 MTOR (0.41) MTORRPTORMLST8CHEK1CCNA2
SCHEMBL45392 0.88 MTOR (0.40) MTORRPTORMLST8CHEK1CCNA2
SCHEMBL30716 0.87 MTOR (0.43) MTORRPTORMLST8CHEK1CCNA2
SCHEMBL15026255 0.87 MTOR (0.43) MTORRPTORMLST8CHEK1CCNA2
SCHEMBL17787556 0.86 MTOR (0.40) MTORRPTORMLST8CHEK1CCNA2
SCHEMBL15007449 0.85 MTOR (0.42) MTORRPTORMLST8CHEK1CCNA2
SCHEMBL41447 0.85 MTOR (0.43) MTORRPTORMLST8CHEK1CCNA2
SCHEMBL42817 0.84 MTOR (0.43) MTORRPTORMLST8CHEK1CCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2608668-B1 FUSED TRICYCLIC INHIBITORS OF MAMMALIAN TARGET OF RAPAMYCIN MERCK SHARP & DOHME (US) 2016-06-01 EP disclosed
WO-2012027234-A1 FUSED TRICYCLIC INHIBITORS OF MAMMALIAN TARGET OF RAPAMYCIN SCHERING CORPORATION (US) 2012-03-01 WO disclosed